Daniel Lin, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Clovis Oncology
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    MagForce USA
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Genomic Health, Inc.
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    NIH/NCI
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Department of Defense
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Clovis Oncology
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    MagForce USA
    Date added:
    Date updated:
    04/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Genomic Health, Inc.
    Date added:
    Date updated:
    04/02/2023

Pages

Return to Active Surveillance for Prostate Cancer (2019)